Hofseth BioCare ASA
HOFBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 32.1% | 61.8% | 37.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.1% | 22.7% | 23.7% | 26.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26.4% | -32.2% | -80.5% | -100.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -47.9% | -54.7% | -114.1% | -144.3% |
| EPS Diluted | -0.3 | -0.27 | -0.37 | -0.35 |
| % Growth | -11.1% | 27% | -5.7% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |